These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23033232)

  • 41. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
    Zikria J; Ansell J
    Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential interaction between pomegranate juice and warfarin.
    Komperda KE
    Pharmacotherapy; 2009 Aug; 29(8):1002-6. PubMed ID: 19637955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A current review of cytochrome P450 interactions of psychotropic drugs.
    Madhusoodanan S; Velama U; Parmar J; Goia D; Brenner R
    Ann Clin Psychiatry; 2014 May; 26(2):120-38. PubMed ID: 24812650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Valproic acid and warfarin: an underrecognized drug interaction.
    Yoon HW; Giraldo EA; Wijdicks EF
    Neurocrit Care; 2011 Aug; 15(1):182-5. PubMed ID: 21512888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytochrome P-450 monooxygenases and interactions of psychotropic drugs.
    Shen WW; Lin KM
    Int J Psychiatry Med; 1991; 21(1):47-56. PubMed ID: 2066257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substitution of generic warfarin for Coumadin in an HMO setting.
    Milligan PE; Banet GA; Waterman AD; Gatchel SK; Gage BF
    Ann Pharmacother; 2002 May; 36(5):764-8. PubMed ID: 11978149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
    Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.
    Davis DA; Fugate SE
    Pharmacotherapy; 2005 Mar; 25(3):442-7. PubMed ID: 15843293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probable interaction between warfarin and torsemide.
    Bird J; Carmona C
    Ann Pharmacother; 2008 Dec; 42(12):1893-8. PubMed ID: 19017829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term drug interaction of warfarin with amiodarone].
    Hirmerová J; Suchý D; Mádr T
    Cas Lek Cesk; 2003 Jan; 142(1):39-42. PubMed ID: 12693297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fifty years of clinical use of warfarin].
    Quintero-González JA
    Invest Clin; 2010 Jun; 51(2):269-87. PubMed ID: 20928982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fenofibrate potentiates warfarin effects.
    Kim KY; Mancano MA
    Ann Pharmacother; 2003 Feb; 37(2):212-5. PubMed ID: 12549950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.